News

Filter

Current filters:

Qiagen

1 to 9 of 14 results

Qiagen signs agreement with Astellas Pharma to develop companion diagnostics

Qiagen signs agreement with Astellas Pharma to develop companion diagnostics

29-10-2014

Netherlands-based company Qiagen has announced a master collaboration agreement with Japanese drug major…

Astellas PharmaJapanLicensingNetherlandsOncologyPharmaceuticalQiagen

Qiagen signs deal with Clovis Oncology to co-develop diagnostic test

Qiagen signs deal with Clovis Oncology to co-develop diagnostic test

24-10-2013

Netherlands company Qiagen has announced a partnership with Clovis Oncology to co-develop and co-commercialize…

BiotechnologyEuropeOncologyQiagenResearchtherascreen EGFR RGQ PCR Kit

UK's NICE recommends tests for non-small-cell lung cancer

14-08-2013

The UK's drugs watchdog the National Institute for Health and Care Excellence (NICE) has today recommended…

EuropeOncologyPharmaceuticalQiagenResearchRoche

US FDA approves Boehringer Ingelheim's first cancer drug

15-07-2013

In what the family-owned German drug major Boehringer Ingelheim hopes is just the first drug to come…

afatinibBiotechnologyBoehringer IngelheimGilotrifNorth AmericaOncologyPharmaceuticalQiagenRegulation

US FDA approves companion diagnostic for Tarceva, and new indication for the Roche drug

15-05-2013

The US Food and Drug Administration late yesterday (May 14) approved Swiss drug major Roche (ROG: SIX)…

Boehringer IngelheimNorth AmericaOncologyPharmaceuticalQiagenRegulationRocheTarcevaTomtovok

Boehringer Ingelheim's afatinib NDA gets priority review in USA

16-01-2013

The US subsidiary of German independent drug major Boehringer Ingelheim revealed yesterday that the New…

afatinibBoehringer IngelheimNorth AmericaOncologyPharmaceuticalQiagenRegulationTomtovok

US FDA approves Erbitux as first-line treatment in KRAS wild-type EGFR

09-07-2012

US drug majors Eli Lilly (NYSE: LLY) and Bristol-Myers Squibb (NYSE: BMY) on Friday received full approval…

Bristol-Myers SquibbEli LillyErbituxNorth AmericaOncologyPharmaceuticalQiagenRegulation

1 to 9 of 14 results

COMPANY SPOTLIGHT

Menarini

Back to top